 |
|
|
|
|
|
|
 |
Intended Use |
|
| |
|
|
|
GlucoDay® S, the latest continuous glucose monitor from Menarini Diagnostics Research, was developed thanks to the collaborative relationship that Menarini Diagnostics has with diabetologists all around Europe.
GlucoDay® S is a useful diagnostic tool to help meet the demands of achieving strict glycaemic control. GlucoDay® S can be used in a variety of situations:
|
|
-
Type 1 diabetes
-
Nocturnal Hypoglycaemia
-
Hypoglycaemic Unawareness
-
Insulin-requiring Type 2 diabetic patients with unstable metabolic control
-
Set up and adjustment of Insulin therapy/Pump therapy
-
Diabetes in pregnancy
-
Gestational diabetes
-
Changing insulin regimens
-
Paediatric diabetes
-
Glycaemic monitoring in Intensive Care Units
|
|
|
|
GlucoDay® S can provide real-time data with improved accuracy in all ranges when compared to the laboratory method. Further areas of use include:
Potential Use:
-
Inconsistency between glucose record diary and HbA1c
-
To evaluate the adequacy of timing and frequency of self-monitored blood glucose
-
To enhance patient education and psychological motivation for optimal diabetes management
-
Dawn phenomenon
|
|
Please be informed that the content of this page is intended for UK residents only
|
|
|
|
|
|
|
